LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Pharmaceutical Care in Digital Revolution
Blending Digital with Human Innovation
- 2nd Edition - August 18, 2023
- Editors: Ardalan Mirzaei, Claudia Rijcken
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 3 6 0 - 2
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 3 6 1 - 9
Pharmaceutical Care in the Digital Revolution: Blending Digital with Human Innovation, Second Edition provides readers with an updated view on how to use technology to improve p… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quotePharmaceutical Care in the Digital Revolution: Blending Digital with Human Innovation, Second Edition provides readers with an updated view on how to use technology to improve pharmaceutical care (PC) and enhance drug outcomes with digital tools. Organized into four parts, including Global Healthcare Systems Under Pressure, Digital Advances to Innovate Pharmaceutical Care Journeys, Conditions to Drive Combinatoric Pharma-Digital Innovation, and What to do Tomorrow as a Pharmaceutical Care Leader, the book further examines digital developments that will optimize the PC process and prepare stakeholders for a dynamic future that will optimize the life of patients against a sustainable cost model.
This edition also discusses recent advances in the digital health arena that will change the way we approach healthcare and prevention while also providing interactive links to lectures and technologies, tutorials on how to implement advances in your own working environment, and examples of pharmacists who are successful in building synergy between digital and pharma.
- Teachers readers about new advances in digital health technology
- Provides updated insights on future pharmaceutical care and how to implement essential conditions to create the best outlook for patients
- Includes updated access links and QR codes as educational material for the book
All stakeholders involved in executing and optimizing future pharmaceutical care pathways which includes pharmacists, pharmacy technicians, academia, pharmaceutical companies, supply chain providers, payers, policy makers, patients and health tech providers
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- About the editors
- About the authors
- Foreword
- Acknowledgments
- Executive summary
- Introduction
- The WHY
- Purpose of book
- Culinary analogy
- Scope of book
- Audience scope
- Geographical scope
- Time scope
- Content scope
- How this book is organized
- Assumptions made
- Icons used in this interactive book
- Beyond the book
- Part 1. Why: global healthcare systems under pressure
- Chapter 1. Pharmacists in need of sustenance
- Sustainability focus
- Patients are in general positive, but expect better
- System change required as nourishment for healthcare system sustainability
- The benefits and budgets of medication in healthcare systems
- Value for medication money
- Chapter 2. Experimental digital: innovation required
- From innovation to value
- General principles of successful innovation
- About disruptive innovation
- The innovation funnel
- Open innovation
- Combinatoric innovation
- Creating the best environment for combinatoric innovation
- Ideas ready to survive in a complex world: “the last mile”
- Risks for failure
- Learning from brilliant failures
- Chapter 3. Healthcare's nutritional value
- Measuring outcomes
- Quadruple aim and proving value of medicine
- The quantified self to measure outcomes
- Driving value as a pharmaceutical care provider
- Chapter 4. Platters of paying for outcomes
- From activity-based to outcome-based financing
- Changing models for spending control on drugs
- Real-world evidence
- Broader societal benefits and health impact bonds
- Pharmaceutical care providers as drug outcome optimizers
- Chapter 5. #Including the consuming patient
- Patient centricity
- Why healthcare systems promote active patient participation
- What do patients consider as good healthcare?
- Shared responsibility
- What patients can expect from pharmaceutical care
- Chapter 6. The pharmaceutical care buffet
- Pharmaceutical care
- From hospital or community to home pharmaceutical care
- Preventing inadequate drug use
- Adherence, its relevance and taxonomy
- Part 2. What: digital advances to innovate pharmaceutical care journeys
- Chapter 7. The digital health technology menu
- Digital health
- Digital health classification by type of data transfer
- Health technology at different stages of the patient pathway
- Technology adoption
- Serious gaming to change habits
- Economic benefits of digital health
- Research on digital health cost-effectiveness
- Chapter 8. Zesting the internet of pharma things
- IoT explosion
- Internet of Health
- Internet of Pharma Things
- Data in the Internet of Things
- Data in the health ecosystem
- HL7-FHIR and the interoperability of healthcare applications
- FAIR data exchange
- Turning health data into knowledge
- Considerations for future IoT uptake
- Privacy and security
- Chapter 9. The spice rack of health apps
- Technology
- Impact on pharmaceutical care activities
- Considerations
- Chapter 10. Infusing wearables
- Technology
- Impact on core responsibilities in pharmaceutical care
- Implementation in daily practice
- Considerations
- Chapter 11. The artificial intelligence pizza
- Technology
- Impact on core responsibilities in pharmaceutical care
- Implementation in daily practice
- Considerations
- Chapter 12. Your chef: the virtual pharmaceutical care assistant
- Technology
- Additional use cases in healthcare
- Impact on core responsibilities in pharmaceutical care
- Considerations
- Chapter 13. The taste of virtual, augmented, and mixed reality
- Technology
- Impact on core responsibilities in pharmaceutical care
- Implementation in daily practice
- Considerations
- Chapter 14. Fusion cooking with pharmacy information systems
- Bringing flavors together
- Technology
- Impact on core responsibilities in pharmaceutical care
- Implementation in daily practice
- Considerations
- Conclusion
- Chapter 15. The molecular gastronomy of digital therapeutics
- Technology
- Impact on core responsibilities in pharmaceutical care
- Implementation in daily practice
- Considerations
- Chapter 16. What's cooking beyond 2028
- Precision medicine
- Pharmacogenetic self testing
- 3D-printed drugs
- Social robots in every home
- Blockchain technology
- Part 3. How: conditions to drive combinatoric pharma-digital innovation
- Chapter 17. Whisking the digital health compliance
- Managing risks
- Compliance blueprint: what to do tomorrow
- Definition of the applicable legal framework
- Chapter 18. The ingredients of ethical practice
- Introduction
- Ethics and moral theory in a technological culture
- Core values and virtue-based pharmaceutical care providers
- Digital ethics
- Technology versus humanity
- Key ethical questions raised by increasing use of technology in pharmaceutical care
- A meaningful life and human flourishing in the digital age
- Final thoughts on ethically sound pharmaceutical care
- Chapter 19. Nourishing education to digitally enable pharmacists
- Introduction
- The future of pharmaceutical care and new roles
- The future of the pharmaceutical care job
- Required knowledge, competencies and skills for future pharmaceutical care providers
- Knowledge domains in pharmaceutical care
- Digital literacy competencies
- Traditional skills required for pharmacists
- General skills required for pharmaceutical care in the digital revolution
- Integrating the new fundamental competency
- Part 4. How: what to do tomorrow as a pharmaceutical care leader
- Chapter 20. Digital by design: recipes for success
- WHY: identify the true pharmaceutical care problem, the why and the blue sky
- WHO: select the most relevant patient group
- WHAT: validate how the target population sees the blue sky
- HOW: choose the most suitable future solution
- How to lead digital transformation
- SUSTAIN: check the new process and adjust where required
- Considerations
- Chapter 21. Broiling the high-performance culture
- Why culture drives results
- The need for clarity, connection, and goals
- How distinctions build a culture focused on the future
- How to use power laws
- The value of strategic quitting
- How to take the first step and maintain momentum
- Chapter 22. Final discussion: blending pharmaceutical care
- Progress in digital health between the first edition (2019) and this second edition
- The overpromised health technologies between the first edition (2019) and this second edition
- The four questions in the foreword
- Final note
- Abbreviations
- Appendix: Overview of laws, legislation, and standards referred to in Chapter 17
- Index
- No. of pages: 438
- Language: English
- Edition: 2
- Published: August 18, 2023
- Imprint: Academic Press
- Paperback ISBN: 9780443133602
- eBook ISBN: 9780443133619
AM
Ardalan Mirzaei
Ardalan (Ardi) Mirzaei, BPharm, MPhil, GradCertEdStud (Higher Ed), PhD is a registered pharmacist and data scientist.
He completed his PhD in the School of Pharmacy, developing a dynamic model of patients' health information-seeking behaviour.
Ardi has worked in community pharmacy for over 15 years, having worked in a clinical setting as well as managing multimillion-dollar stores. In addition, he has a background in education, working as a training coordinator for pharmacy internships and teaching at the University of Sydney on subjects in business, pharmacy, and machine learning.
This is supplemented with over eight years of experience in data science, developing business solutions for the healthcare, education, retail, academic and government sectors. His passions include health, teaching and technology.
Ardi enjoys exploring the use of AI, machine learning and deep learning models and their application to everyday tasks and in healthcare. His interests have led to his involvement in the International Pharmaceutical Federation (FIP) Technology Advisory Group.
Affiliations and expertise
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, AustraliaCR
Claudia Rijcken
Claudia has an educational background as a pharmacist and obtained a PhD in Pharmacoepidemiology and a Master of Health Administration (eMBA).
After managing community pharmacy roles, she moved into clinical drug development in roles with increasing responsibility at Organon and Novartis.
Next, she acted within Novartis in international leadership roles in patient access, key account management, and public affairs. Here, Claudia developed a growing passion to educate an facilitate the adequate use of digital health technology to further enhance the value of pharmaceutical care.
She invested in learning about business development and health technology at Erasmus University Rotterdam and MIT Sloan and moved into a European digital innovation role within Novartis.
In 2019, Claudia founded the company Pharmi BV which is located at the Philips High Tech Campus in Eindhoven, the Netherlands.
Pharmi develops interactive digital medication care modules that facilitate blended care support to patients. It offers pharmacists the possibility to provide care digitally where possible, freeing up more time to provide the ultimate important human care where needed. Pharmi’s platform MedsWise acts as an interactive digital coach for patients, warranting 24/7 patient access to reliable information, interaction and support at respective patient literacy levels and preferences.
Claudia is since 2019 also lecturer in digital pharmaceutical care for MSc Pharmacy students at the University of Utrecht, Netherlands. She regularly lectures on national and international events on digital pharmaceutical care and the transformation of care models.
Claudia is an active member of the FIP Technology Advisory Group.
Read Pharmaceutical Care in Digital Revolution on ScienceDirect